Clare J Lee1, Geetha Iyer2, Yang Liu2, Rita R Kalyani3, N'Dama Bamba4, Colin B Ligon5, Sanskriti Varma6, Nestoras Mathioudakis3. 1. Division of Endocrinology, Diabetes & Metabolism, The Johns Hopkins University, Baltimore, MD, USA. Electronic address: clee158@jhmi.edu. 2. The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 3. Division of Endocrinology, Diabetes & Metabolism, The Johns Hopkins University, Baltimore, MD, USA. 4. The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Division of Infectious Diseases, The Johns Hopkins University, Baltimore, MD, USA; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD, USA. 5. Division of Rheumatology, The Johns Hopkins University, Baltimore, MD, USA. 6. The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract
AIMS: We aimed to assess whether vitamin D supplementation improves glucose metabolism in adults with type 2 diabetes. METHODS: PubMed and Cochrane database were searched up to July 1st 2016 for randomized controlled trials that assessed the relationship between vitamin D supplementation and glucose metabolism (change in hemoglobin A1C (HbA1C) and fasting blood glucose (FBG)) among adults with type 2 diabetes. RESULTS: Twenty nine trials (3324 participants) were included in the systematic review. Among 22 studies included in the meta-analysis, 19 reported HbA1C, 16 reported FBG outcomes and 15 were deemed poor quality. There was a modest reduction in HbA1C (-0.32% [-0.53 to -0.10], I2=91.9%) compared to placebo after vitamin D supplementation but no effect on FBG (-2.33mg/dl [-6.62 to 1.95], I2=59.2%). In studies achieving repletion of vitamin D deficiency (n=7), there were greater mean reductions in HbA1C (-0.45%, [-1.09 to 0.20]) and FBG (-7.64mg/dl [-16.25 to 0.97]) although not significant. CONCLUSIONS: We found a modest reduction of HbA1C after vitamin D treatment in adults with type 2 diabetes albeit with substantial heterogeneity between studies and no difference in FBG. Larger studies are needed to further evaluate the glycemic effects of vitamin D treatment especially in patients with vitamin D deficiency.
AIMS: We aimed to assess whether vitamin D supplementation improves glucose metabolism in adults with type 2 diabetes. METHODS: PubMed and Cochrane database were searched up to July 1st 2016 for randomized controlled trials that assessed the relationship between vitamin D supplementation and glucose metabolism (change in hemoglobin A1C (HbA1C) and fasting blood glucose (FBG)) among adults with type 2 diabetes. RESULTS: Twenty nine trials (3324 participants) were included in the systematic review. Among 22 studies included in the meta-analysis, 19 reported HbA1C, 16 reported FBG outcomes and 15 were deemed poor quality. There was a modest reduction in HbA1C (-0.32% [-0.53 to -0.10], I2=91.9%) compared to placebo after vitamin D supplementation but no effect on FBG (-2.33mg/dl [-6.62 to 1.95], I2=59.2%). In studies achieving repletion of vitamin D deficiency (n=7), there were greater mean reductions in HbA1C (-0.45%, [-1.09 to 0.20]) and FBG (-7.64mg/dl [-16.25 to 0.97]) although not significant. CONCLUSIONS: We found a modest reduction of HbA1C after vitamin D treatment in adults with type 2 diabetes albeit with substantial heterogeneity between studies and no difference in FBG. Larger studies are needed to further evaluate the glycemic effects of vitamin D treatment especially in patients with vitamin D deficiency.
Authors: Yvonne H M Krul-Poel; Sanne Westra; Edwin ten Boekel; Marieke M ter Wee; Natasja M van Schoor; Hans van Wijland; Frank Stam; Paul T A M Lips; Suat Simsek Journal: Diabetes Care Date: 2015-05-13 Impact factor: 19.112
Authors: F Strobel; J Reusch; M Penna-Martinez; E Ramos-Lopez; E Klahold; C Klepzig; J Wehrle; H Kahles; K Badenhoop Journal: Horm Metab Res Date: 2013-11-06 Impact factor: 2.936
Authors: Mirjam M Oosterwerff; Elisabeth Mw Eekhoff; Natasja M Van Schoor; A Joan P Boeke; Prabath Nanayakkara; Rosa Meijnen; Dirk L Knol; Mark Hh Kramer; Paul Lips Journal: Am J Clin Nutr Date: 2014-06-04 Impact factor: 7.045
Authors: A Sadiya; S M Ahmed; M Carlsson; Y Tesfa; M George; S H Ali; H H Siddieg; S Abusnana Journal: Eur J Clin Nutr Date: 2014-11-19 Impact factor: 4.016
Authors: Ilaria Barchetta; Maria Del Ben; Francesco Angelico; Michele Di Martino; Antonio Fraioli; Giuseppe La Torre; Rosella Saulle; Ludovica Perri; Sergio Morini; Claudio Tiberti; Laura Bertoccini; Flavia Agata Cimini; Francesca Panimolle; Carlo Catalano; Marco Giorgio Baroni; Maria Gisella Cavallo Journal: BMC Med Date: 2016-06-29 Impact factor: 8.775
Authors: Jürgen Harreiter; Gernot Desoye; Mireille N M van Poppel; Alexandra Kautzky-Willer; Fidelma Dunne; Rosa Corcoy; Roland Devlieger; David Simmons; Juan M Adelantado; Peter Damm; Elizabeth Reinhardt Mathiesen; Dorte Moeller Jensen; Lise Lotte T Anderson; Annunziata Lapolla; Maria G Dalfrà; Alessandra Bertolotto; Ewa Wender-Ozegowska; Agnieszka Zawiejska; David J Hill; Frank J Snoek Journal: Curr Diab Rep Date: 2019-12-16 Impact factor: 4.810